investor.pdl.comInvestor Relations | PDL BioPharma, Inc.
investor.pdl.com Profile
Investor.pdl.com is a subdomain of pdl.com, which was created on 1994-03-04,making it 30 years ago.
Description：The Investor Relations website contains information about PDL BioPharma, Inc.'s business for stockholders, potential investors, and financial...
Discover investor.pdl.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
investor.pdl.com Information
| HomePage size: 57.791 KB |
| Page Load Time: 0.597894 Seconds |
| Website IP Address: 23.55.192.172 |
investor.pdl.com Similar Website
| Masonite International Corp. - Investor Relations - Investor Relations |
| Block, Inc. (SQ) Investor Relations - Investor Relations |
| Gen Investor Relations - Investor Relations |
| MindChamps PreSchool Limited - Investor Relations: Investor Relations |
| Home - Ayala Land Investor Relations : Ayala Land Investor Relations |
| Investor Relations :: Sutro Biopharma, Inc. (STRO) |
| Universal Technical Institute's Investor Relations - UTI Investor Relations |
| Ameriprise Financial Investor Relations | Investor Relations |
| Meridian Bank Investor Relations - Meridian Bank Investor Relations |
| Armstrong World Industries Investor Relations | Armstrong Flooring Investor Relations |
| Walmart Investor Relations - Investor Relations |
| Alphabet Investor Relations - Investor Relations - Alphabet |
investor.pdl.com PopUrls
| Home | PDL BioPharma, Inc. https://investor.pdl.com/ |
| Investor Relations | PDL BioPharma, Inc. https://investor.pdl.com/investor-relations |
| Investor Updates | PDL BioPharma, Inc. https://investor.pdl.com/investor-updates |
| Stock Information | PDL BioPharma, Inc. https://investor.pdl.com/investor-relations/stock-information |
| Financials & Filings | PDL BioPharma, Inc. https://investor.pdl.com/investor-relations/financials-filings |
| Press Releases | PDL BioPharma, Inc. https://investor.pdl.com/investor-relations/press-releases |
| Annual Reports and Proxies | PDL BioPharma, Inc. https://investor.pdl.com/investor-relations/financials-filings/annual-reports-and-proxies |
| Quarterly Results | PDL BioPharma, Inc. https://investor.pdl.com/investor-relations/financials-filings/quarterly-results |
| SEC Filings | PDL BioPharma, Inc. https://investor.pdl.com/investor-relations/sec-filings |
investor.pdl.com Httpheader
| Accept-Ranges: bytes |
| Content-Encoding: gzip |
| Content-Language: en |
| Content-Type: text/html; charset=UTF-8 |
| device: desktop |
| ETag: "1583079845" |
| Expect-CT: max-age=0, report-uri="/report-expect-ct-violation" |
| Feature-Policy: "accelerometer none;ambient-light-sensor none;autoplay self;camera none;encrypted-media none;fullscreen self;geolocation self;gyroscope none;magnetometer none;microphone none;midi none;payment none;picture-in-picture none;speaker self;sync-xhr self;usb none;vibrate none;vr none", From-Origin: same |
| Last-Modified: Sun, 01 Mar 2020 16:24:05 GMT |
| Link: http://investor.pdl.com/; rel="shortlink", http://investor.pdl.com/; rel="canonical", http://investor.pdl.com/investor-relations; rel="alternate"; hreflang="en", http://investor.pdl.com/investor-relations; rel="revision" |
| Referrer-Policy: no-referrer-when-downgrade |
| Server: nginx |
| X-Age: 0 |
| X-Content-Type-Options: nosniff |
| X-Drupal-Dynamic-Cache: UNCACHEABLE |
| X-Frame-Options: SAMEORIGIN |
| X-Generator: Drupal 8 (https://www.drupal.org) |
| X-Request-ID: v-11e95d04-5bd9-11ea-a184-578e5c669cbf |
| X-UA-Compatible: IE=edge |
| X-XSS-Protection: 1; mode=block |
| X-EdgeConnect-MidMile-RTT: 41 |
| X-EdgeConnect-Origin-MEX-Latency: 487 |
| X-Akamai-Transformed: 9 11924 0 pmb=mRUM,1 |
| Cache-Control: public, max-age=0, s-maxage=1800 |
| Expires: Sun, 01 Mar 2020 16:24:05 GMT |
| Date: Sun, 01 Mar 2020 16:24:05 GMT |
| Content-Length: 12322 |
| Connection: keep-alive |
| Vary: Accept-Encoding |
| Set-Cookie: SimpleSAMLSessionID=2b212a00c0215f19f92ce89771df1c44; path=/; secure; HttpOnly, DrupalVisitorMobile=0; path=/; Secure; HttpOnly |
investor.pdl.com Meta Info
| charset="utf-8"/ |
| content="Investor Relations | PDL BioPharma, Inc." name="title"/ |
| content="PDL BioPharma, Inc." property="og:site_name"/ |
| content="website" property="og:type"/ |
| content="The Investor Relations website contains information about PDL BioPharma, Inc.'s business for stockholders, potential investors, and financial analysts." name="description"/ |
| content="http://investor.pdl.com/investor-relations" property="og:url"/ |
| content="Investor Relations | PDL BioPharma, Inc." property="og:title"/ |
| content="no-referrer" name="referrer"/ |
| content="The Investor Relations website contains information about PDL BioPharma, Inc.'s business for stockholders, potential investors, and financial analysts." property="og:description"/ |
| content="Drupal 8 (https://www.drupal.org)" name="Generator"/ |
| content="width" name="MobileOptimized"/ |
| content="true" name="HandheldFriendly"/ |
| content="width=device-width, initial-scale=1.0" name="viewport"/ |
investor.pdl.com Ip Information
| Ip Country: United States |
| Latitude: 37.751 |
| Longitude: -97.822 |
investor.pdl.com Html To Plain Text
PDL Leadership Equity Investments Noden Noden’s Products Lensar LENSAR Product Alternative Financings Portfolio of Assets On-Going Transactions Concluded Transactions Investor Relations News Contact About PDL Management Equity Investments Noden Noden’s Products Lensar LENSAR Product Alternative Financings Portfolio of Assets On-Going Transactions Concluded Transactions Investor Relations News Contact Investor Relations PDLInvestor Relations Investor Relations PDL BioPharma (Nasdaq: PDLI) seeks to provide a significant return for our shareholders by investing in late clinical-stage or early commercial-stage pharmaceutical assets that can benefit from accessing our capital and expertise. 3 mo. 6 mo. 1 yr. Press Releases Feb 28, 2020 PDL BioPharma Enters into Cooperation Agreement with Engine Capital Feb 25, 2020 PDL BioPharma to Participate in the Cowen and Company 40th Annual Health Care Conference View all press releases » Events & Presentations Dec 9, 2019 9:00 AM EST PDL BioPharma Business Update View all events & presentations » Investor Relations Press Releases Events & Presentations Corporate Governance Financials & Filings Tax Information SEC Filings Stock Information Contact Us Current Alternative Investments Learn More Shareholder Tools Printed Materials Email Alerts RSS Print Share Search Facebook Google LinkedIn Twitter RSS Close Terms of Use Sitemap © Copyright 2019 PDL BioPHARMA. All Rights...
investor.pdl.com Whois
Domain Name: PDL.COM Registry Domain ID: 867_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.networksolutions.com Registrar URL: http://networksolutions.com Updated Date: 2024-03-05T05:29:58Z Creation Date: 1994-03-04T05:00:00Z Registry Expiry Date: 2034-03-05T05:00:00Z Registrar: Network Solutions, LLC Registrar IANA ID: 2 Registrar Abuse Contact Email: domain.operations@web.com Registrar Abuse Contact Phone: +1.8777228662 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS23.WORLDNIC.COM Name Server: NS24.WORLDNIC.COM DNSSEC: unsigned >>> Last update of whois database: 2024-05-17T19:43:59Z <<<